Documentation Centre

 

 

  of 1802 Next page

Go to page: of

Screenshot Date Categories Title Author Format
Nonalcoholic fatty liver disease: An emerging driver of cardiac arrhythmia. Circ Res. 2021;128:1747-1765 November 30, 2021 Nonalcoholic fatty liver disease: An emerging driver of cardiac arrhythmia. Circ Res. 2021;128:1747-1765 Chen Z, Liu J, Zhou F, Li H, Zhang XJ, She ZG, Lu Z, Cai J, Li H Key Publications
Fat-secreted ceramides regulate vascular redox state and influence outcomes in patients with cardiovascular disease. J Am Coll Cardiol. 2021;77:2494-2513 November 26, 2021 Fat-secreted ceramides regulate vascular redox state and influence outcomes in patients with cardiovascular disease. J Am Coll Cardiol. 2021;77:2494-2513 Akawi N, Checa A, Antonopoulos AS, Akoumianakis I, Daskalaki E, Kotanidis CP, Kondo H, Lee K, Yesilyurt D, Badi I, Polkinghorne M, Akbar N, Lundgren J, Chuaiphichai S, Choudhury R, Neubauer S, Channon KM, Torekov SS, Wheelock CE, Antoniades C Key Publications
The role of adipose tissue in cardiovascular disease: Decoding its secret language. J Am Coll Cardiol. 2021;77:2514-2516 November 26, 2021 The role of adipose tissue in cardiovascular disease: Decoding its secret language. J Am Coll Cardiol. 2021;77:2514-2516 O'Donoghue ML, Marston NA Key Publications
Role of sex hormones in cardiovascular diseases. Nat Rev Cardiol. 2021;18:385 November 25, 2021 Role of sex hormones in cardiovascular diseases. Nat Rev Cardiol. 2021;18:385 Lim GB Key Publications
Type 2 diabetes subgroups, risk for complications, and differential effects due to an intensive lifestyle intervention. Diabetes Care. 2021;44:1203-1210 November 22, 2021 Type 2 diabetes subgroups, risk for complications, and differential effects due to an intensive lifestyle intervention. Diabetes Care. 2021;44:1203-1210 Bancks MP, Chen H, Balasubramanyam A, Bertoni AG, Espeland MA, Kahn SE, Pilla S, Vaughan E, Wagenknecht LE; Look AHEAD Research Group Key Publications
Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021;119:154766 November 19, 2021 Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021;119:154766 Hill MA, Yang Y, Zhang L, Sun Z, Jia G, Parrish AR, Sowers JR Key Publications
Diabetic patients with cardiovascular disease show more metabolic syndrome than nondiabetic patients: Multicentric study in the Northeast of Brazil. Metab Syndr Relat Disord. 2021;19:233-239 November 17, 2021 Diabetic patients with cardiovascular disease show more metabolic syndrome than nondiabetic patients: Multicentric study in the Northeast of Brazil. Metab Syndr Relat Disord. 2021;19:233-239 de Brito Gonçalves Nascimento L, Sahade V, Weber B, Pinheiro JMF, Dias LPP, Figueiredo Neto JA, Carlos Sobral Sousa A, Pinho CPS, Luna AB, Vasconcelos SML, Dantas CF, Penafort AM, Carlos DMO, Daltro C Key Publications
Five-color Nutri-Score labeling and mortality risk in a nationwide, population-based cohort in Spain: the Study on Nutrition and Cardiovascular Risk in Spain (ENRICA). Am J Clin Nutr. 2021;113:1301-1311 November 12, 2021 Five-color Nutri-Score labeling and mortality risk in a nationwide, population-based cohort in Spain: the Study on Nutrition and Cardiovascular Risk in Spain (ENRICA). Am J Clin Nutr. 2021;113:1301-1311 Donat-Vargas C, Sandoval-Insausti H, Rey-García J, Ramón Banegas J, Rodríguez-Artalejo F, Guallar-Castillón P Key Publications
Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force. Atherosclerosis. 2021;325:99-109. November 11, 2021 Practical guidance for combination lipid-modifying therapy in high- and very-high-risk patients: A statement from a European Atherosclerosis Society Task Force. Atherosclerosis. 2021;325:99-109. Averna M, Banach M, Bruckert E, Drexel H, Farnier M, Gaita D, Magni P, März W, Masana L, Mello E Silva A, Reiner Z, Ros E, Vrablik M, Zambon A, Zamorano JL, Stock JK, Tokgözoğlu LS, Catapano AL Key Publications
Diabetes duration and glycaemic control as predictors of cardiovascular disease and mortality. Diabetes Obes Metab. 2021;23:1361-1370 November 10, 2021 Diabetes duration and glycaemic control as predictors of cardiovascular disease and mortality. Diabetes Obes Metab. 2021;23:1361-1370 Li FR, Yang HL, Zhou R, Zheng JZ, Chen GC, Zou MC, Wu XX, Wu XB Key Publications

  of 1802 Next page

Go to page: of